netFormulary Berkshire West NHS NHS
Royal Berkshire Foundation Trust
Berkshire Healthcare NHS Foundation Trust
Newbury and District CCG
North and West Reading CCG
South Reading CCG
Wokingham CCG
 
 Search
 Formulary Chapter 6: Endocrine system - Full Section
Notes:
This formulary is used by multiple organisations. There may be some instances where an item is on the formulary for one organisation but not the others. To help distinguish between each organisation, text will be colour coded, i.e. information relating to the Royal Berkshire NHS Foundation Trust will be in blue and Berkshire Healthcare NHS Foundation Trust will be in purple. Please ensure you read all information detailed under a drug.   
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
06.01 Drugs used in diabetes (0,0)
06.01.01 Insulins (0,0)
06.01.01.01 Short-acting insulins (4,9)
06.01.01.02 Intermediate- and long-acting insulins (6,7)
Biphasic insulins (3,8)
06.01.01.03 Hypodermic equipment (0,7)
06.01.02 Antidiabetic drugs (0,0)
06.01.02.01 Sulphonyureas (3,12)
06.01.02.02 Biguanides (2,4)
06.01.02.03 Other antidiabetic drugs (14,9)
06.01.03 Diabetic ketoacidosis (0,0)
06.01.04 Treatment of hypoglycaemia (2,1)
Chronic hypoglycaemia (0,1)
06.01.05 Treatment of diabetic nephropathy and neuropathy (0,0)
Diabetic nephropathy (0,0)
Diabetic neuropathy (0,0)
06.01.06 Diagnostic and monitoring agents for diabetes mellitus (0,2)
Blood glucose monitoring (0,37)
Urinalysis (7,16)
Oral glucose tolerance test (0,3)
06.02 Thyroid and Antithyroid drugs (0,0)
06.02.01 Thyroid hormones (2,1)
06.02.02 Antithyroid drugs (3,0)
06.03 Corticosteroids (0,0)
06.03.01 Replacement therapy (1,0)
06.03.02 Glucocorticoid therapy (5,8)
Disadvantages of corticosteroids (0,0)
Use of corticosteroids (0,0)
Pregnancy and breastfeeding (0,0)
Administration (0,0)
Withdrawal of corticosteroids (0,0)
06.04 Sex hormones (0,0)
06.04.01 Female sex hormones (0,1)
06.04.01.01 Oestrogens and HRT (4,39)
Hormone replacement therapy (0,0)
Ethinylestradiol (0,1)
Raloxifene (1,0)
06.04.01.02 Progestogens (4,7)
06.04.02 Male sex hormones and antagonists (4,10)
Anti-androgens (2,2)
06.04.03 Anabolic steroids (0,1)
06.05 Hypothalamic and pituitary hormones and anti-oestrogens (0,1)
06.05.01 Hypothalamic and anterior pituitary hormones and anti-oestrogens (0,0)
Anti-oestrogens (1,1)
Anterior pituitary hormones (6,7)
Hypothalmic hormones (2,2)
06.05.02 Posterior pituitary hormones and antagonists (0,0)
Posterior pituitary hormones (3,5)
Antidiuretic hormone antagonists (1,0)
06.06 Drugs affecting bone metabolism (0,0)
Osteoporosis (0,0)
06.06.01 Calcitonin and parathyroid hormone (1,3)
06.06.02 Bisphosphonates and other drugs affecting bone metabolism (0,0)
Bisphosphonates (9,12)
Denosumab (2,0)
Strontium renelate (1,0)
06.07 Other endocrine drugs (0,0)
06.07.01 Bromocriptine and other dopaminergic drugs (2,2)
06.07.02 Drugs affecting gonadotrophins (1,4)
Gonadorelin analogues (5,3)
Breast pain (mastalgia) (0,0)
06.07.03 Metyrapone (0,2)
06.07.04 Somatomedins (0,1)
netFormulary